Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Cancer Causes Control. 2017 Mar 13;28(5):371–383. doi: 10.1007/s10552-017-0876-0

Table 3.

Association between duration of OC use and ovarian cancer risk among Nurses’ Health Study II participants (1989-2013)

Model 1a Model 2b Model 3c
Cases Person-yrs HR 95% CI HR 95% CI HR 95% CI
Duration of OC use
 Never 36 321,519 1.00 (Ref). 1.00 (Ref). 1.00 (Ref).
 ≤6 months 33 165,347 1.65 (1.02, 2.64) 1.78 (1.10, 2.85) 1.82 (1.13, 2.93)
 ≥6 months – 1 year 25 159,328 1.36 (0.82, 2.27) 1.46 (0.87, 2.44) 1.51 (0.90, 2.53)
 >1-<5 years 96 679,339 1.19 (0.81, 1.75) 1.29 (0.88, 1.90) 1.33 (0.90, 1.97)
 5-<10 years 59 551,456 0.95 (0.63, 1.44) 0.98 (0.65, 1.49) 1.03 (0.67, 1.56)
 10-<15 years 26 207,436 1.10 (0.66, 1.83) 1.06 (0.63, 1.76) 1.11 (0.66, 1.84)
 ≥15 years 6 94,253 0.47 (0.20, 1.11) 0.40 (0.17, 0.96) 0.43 (0.18, 1.04)
p-trendd 0.02 0.003 0.006
p-trende 0.003 0.0003 0.0005
a

Adjusted for age (years) and calendar time

b

Adjusted for Model 1 variables + tubal ligation (yes/no), parity (number of pregnancies), breastfeeding duration (months), and missing breastfeeding duration, laparoscopically-confirmed endometriosis (ever/never)

c

Adjusted for Model 2 variables + body mass index (kg/m2)

d

P-trend is calculated including the never OC users

e

P-trend is calculated among ever OC users